Cerberus v. Canadian Imperial Bank of Commerce: Representing Cerberus-affiliated investment vehicles in lawsuit bringing breach of contract claims against CIBC, stemming from CIBC’s payment obligations related to cash and synthetic assets in its U.S. residential housing portfolio.
Chesapeake Energy (various matters): Representing Chesapeake Energy and corporate affiliates in numerous class and individual actions brought by lessors challenging royalty payments pursuant to oil & gas leases.
Watts v. Amoco: Representing BP America in lawsuit by royalty owners alleging fraud and breach of contract claims.
In re Ranbaxy Generic Drug Application Antitrust Litigation: Representing Sun Pharma and its subsidiary, Ranbaxy, in a putative class action litigation alleging Ranbaxy obstructed competition by making fraudulent misrepresentations to the FDA in seeking approval for its generic versions of blockbuster drugs, Nexium®, Valcyte® and Diovan®.
In re Niaspan Antitrust Litigation: Representing Teva and its affiliate, Barr Pharmaceuticals, in a multidistrict class action litigation arising out of a patent litigation settlement concerning the cholesterol drug Niaspan®.
In re Lipitor Antitrust Litigation: Representing Ranbaxy in a putative class action litigation arising out of a patent litigation settlement concerning the cholesterol drug Lipitor®.
In re Effexor XR Antitrust Litigation: Representing Teva in a putative class action litigation arising out of a patent litigation settlement concerning the antidepressant drug Effexor®.
